Kang Minyong, Jeong Chang Wook, Kwak Cheol, Kim Hyeon Hoe, Ku Ja Hyeon
Department of Urology, Seoul National University Bundang Hospital, Kyeonggi-do, Seongnam City, Republic of Korea.
Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea.
Ann Surg Oncol. 2016 Jan;23(1):335-42. doi: 10.1245/s10434-015-4708-8. Epub 2015 Jul 8.
Because the pretreatment neutrophil-to-lymphocyte ratio (NLR) is a reliable prognostic factor, the authors of this study hypothesized that posttreatment NLR also predicts the survival outcome for cancer patients. The study investigated the clinicopathologic features according to postoperative NLR and determined the prognostic significance of early postoperative NLR for bladder cancer patients undergoing radical cystectomy (RC).
The study reviewed 385 bladder cancer patients treated with RC and pelvic lymph node dissection at the authors' institution between 1999 and 2012. The primary end points of the study were cancer-specific survival (CSS) and overall survival (OS) estimates from the Kaplan-Meier analysis. Multivariate Cox regression analysis was adopted to identify the independent prognostic factors for oncologic outcomes after surgery.
Patients with elevated postoperative NLR (≥2.0) had higher rates of advanced pathologic tumor stage (≥pT3), lymphovascular invasion, and lymph node involvement. Notably, they showed poorer CSS and OS rates than patients with a postoperative NLR lower than 2.0. Additionally, patients with pre- and postoperative elevated NLR (≥2.1 → ≥2.0) demonstrated worse oncologic outcomes than other groups of NLR changes. Multivariate analysis showed that early postoperative NLR remained a key predictor for CSS and OS. When divided by pathologic T or N stage, patients with localized pathologic T stage or pN0 status showed significant differences in survival according to early postoperative NLR.
In summary, postoperative NLR in the early recovery period can be a valuable biomarker for predicting oncologic outcomes for bladder cancer patients undergoing RC.
由于治疗前中性粒细胞与淋巴细胞比值(NLR)是一个可靠的预后因素,本研究的作者推测治疗后NLR也可预测癌症患者的生存结果。该研究根据术后NLR调查了临床病理特征,并确定了早期术后NLR对接受根治性膀胱切除术(RC)的膀胱癌患者的预后意义。
该研究回顾了1999年至2012年期间在作者所在机构接受RC和盆腔淋巴结清扫术的385例膀胱癌患者。该研究的主要终点是通过Kaplan-Meier分析得出的癌症特异性生存(CSS)和总生存(OS)估计值。采用多变量Cox回归分析来确定术后肿瘤学结果的独立预后因素。
术后NLR升高(≥2.0)的患者具有更高的晚期病理肿瘤分期(≥pT3)、淋巴管侵犯和淋巴结受累率。值得注意的是,他们的CSS和OS率比术后NLR低于2.0的患者更差。此外,术前和术后NLR升高(≥2.1 → ≥2.0)的患者的肿瘤学结果比其他NLR变化组更差。多变量分析表明,早期术后NLR仍然是CSS和OS的关键预测因素。按病理T或N分期划分时,局部病理T分期或pN0状态的患者根据早期术后NLR在生存方面存在显著差异。
总之,早期恢复期的术后NLR可以成为预测接受RC的膀胱癌患者肿瘤学结果的有价值的生物标志物。